Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: FABRY DISEASE - COMPLICATIONS , . Treffer: 11

2017

Finsterer, J; Wanschitz, J; Quasthoff, S; Iglseder, S; Löscher, W; Grisold, W Causally treatable, hereditary neuropathies in Fabry's disease, transthyretin-related familial amyloidosis, and Pompe's disease.
Acta Neurol Scand. 2017; 136(6):558-569 Doi: 10.1111/ane.12758
Web of Science PubMed FullText FullText_MUG

 

Odler, B; Cseh, Á; Constantin, T; Fekete, G; Losonczy, G; Tamási, L; Benke, K; Szilveszter, B; Müller, V Long time enzyme replacement therapy stabilizes obstructive lung disease and alters peripheral immune cell subsets in Fabry patients.
Clin Respir J. 2017; 11(6): 942-950. Doi: 10.1111/crj.12446
Web of Science PubMed FullText FullText_MUG

 

2015

Fazekas, F; Enzinger, C; Schmidt, R; Grittner, U; Giese, AK; Hennerici, MG; Huber, R; Jungehulsing, GJ; Kaps, M; Kessler, C; Martus, P; Putaala, J; Ropele, S; Tanislav, C; Tatlisumak, T; Thijs, V; von Sarnowski, B; Norrving, B; Rolfs, A; SIFAP 1 Investigators Brain magnetic resonance imaging findings fail to suspect Fabry disease in young patients with an acute cerebrovascular event.
Stroke. 2015; 46(6):1548-1553 Doi: 10.1161/STROKEAHA.114.008548 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Zampetti, A; Orteu, CH; Antuzzi, D; Bongiorno, MR; Manco, S; Gnarra, M; Morrone, A; Cardinali, G; Kovacs, D; Aspite, N; Linder, D; Parini, R; Feliciani, C; Interdisciplinary Study Group on Fabry Disease (ISGF) Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.
Br J Dermatol. 2012; 166(4): 712-720. Doi: 10.1111/j.1365-2133.2012.10742.x
Web of Science PubMed FullText FullText_MUG

 

2011

Fellgiebel, A; Keller, I; Martus, P; Ropele, S; Yakushev, I; Böttcher, T; Fazekas, F; Rolfs, A Basilar artery diameter is a potential screening tool for fabry disease in young stroke patients.
Cerebrovasc Dis. 2011; 31(3): 294-299. Doi: 10.1159/000322558
Web of Science PubMed FullText FullText_MUG

 

Mundigler, G; Gaggl, M; Heinze, G; Graf, S; Zehetgruber, M; Lajic, N; Voigtländer, T; Mannhalter, C; Sunder-Plassmann, R; Paschke, E; Fauler, G; Sunder-Plassmann, G The endocardial binary appearance ('binary sign') is an unreliable marker for echocardiographic detection of Fabry disease in patients with left ventricular hypertrophy.
Eur J Echocardiogr. 2011; 12(10):744-749 Doi: 10.1093/ejechocard/jer112 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Niemann, M; Herrmann, S; Hu, K; Breunig, F; Strotmann, J; Beer, M; Machann, W; Voelker, W; Ertl, G; Wanner, C; Weidemann, F Differences in Fabry Cardiomyopathy Between Female and Male Patients Consequences for Diagnostic Assessment
JACC Cardiovasc Imaging. 2011; 4(6):592-601 Doi: 10.1016/j.jcmg.2011.01.020 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Tanislav, C; Kaps, M; Rolfs, A; Böttcher, T; Lackner, K; Paschke, E; Mascher, H; Laue, M; Blaes, F Frequency of Fabry disease in patients with small-fibre neuropathy of unknown aetiology: a pilot study.
Eur J Neurol. 2011; 18(4):631-636 Doi: 10.1111/j.1468-1331.2010.03227.x
Web of Science PubMed FullText FullText_MUG

 

2009

Weidemann, F; Niemann, M; Breunig, F; Herrmann, S; Beer, M; Stork, S; Voelker, W; Ertl, G; Wanner, C; Strotmann, J Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy Evidence for a Better Outcome With Early Treatment
Circulation. 2009; 119(4):524-529 Doi: 10.1161/CIRCULATIONAHA.108.794529 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2005

Weidemann, F; Breunig, F; Beer, M; Sandstede, J; Stork, S; Voelker, W; Ertl, G; Knoll, A; Wanner, C; Strotmann, JM The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease
Eur Heart J. 2005; 26(12):1221-1227 Doi: 10.1093/eurheartj/ehi143 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2004

Kotanko, P; Kramar, R; Devrnja, D; Paschke, E; Voigtländer, T; Auinger, M; Pagliardini, S; Spada, M; Demmelbauer, K; Lorenz, M; Hauser, AC; Kofler, HJ; Lhotta, K; Neyer, U; Pronai, W; Wallner, M; Wieser, C; Wiesholzer, M; Zodl, H; Födinger, M; Sunder-Plassmann, G Results of a nationwide screening for Anderson-Fabry disease among dialysis patients.
J Am Soc Nephrol. 2004; 15(5):1323-1329 Doi: 10.1097/01.ASN.0000124671.61963.IE [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum